^
Association details:
Evidence:
Evidence Level:
Sensitive: C4 – Case Studies
Title:

P-071 Use of checkpoint inhibitors in hereditary angioedema patient with melanoma: first world case report.

Published date:
04/15/2021
Excerpt:
A 60-years-old woman presented in July 2020 with a painful subscapular dorsal mass... she was diagnosed from primary fusocellular melanoma... molecular testing confirmed the presence of NRAS p.Q61R...Nivolumab 3mg/kg in combination with ipilimumab 1mg/kg treatment was initiated....After 6thcycle of treatment, on 08 February, a PET CT performed showing complete response (CR) of disease.